China Pharma Holdings Inc Financial Flexibility Index
China Pharma Holdings Inc financial flexibility index. China Pharma Holdings Inc (CPHI) has a Financial Flexibility Index of -0.03x as of September 2025. Free cash flow of $-236.37K (operating CF $-236.99K minus capex $613.00) represents 0% of total liabilities ($7.49 Million). See CPHI free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of China Pharma Holdings Inc (2001–2024)
Financial flexibility index of China Pharma Holdings Inc from 2001 to 2024. Historical Financial Flexibility Index trend for China Pharma Holdings Inc across 24 annual periods. Check earnings quality score of China Pharma Holdings Inc to evaluate the quality of earnings relative to operating cash generation.
China Pharma Holdings Inc Financial Flexibility Index by Year (2001–2024)
China Pharma Holdings Inc financial flexibility index by year from 2001 to 2024. Year-by-year free cash flow to debt coverage for China Pharma Holdings Inc. For the full cash flow conversion analysis, see China Pharma Holdings Inc (CPHI) cash conversion ratio.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -0.02x | $-174.64K | $-466.36K | $7.14 Million | ▲ +68.0% |
| 2023 | -0.08x | $-688.17K | $-699.69K | $9.01 Million | ▼ -13488.4% |
| 2022 | 0.00x | $-7.58K | $-409.55K | $13.49 Million | ▼ -105.0% |
| 2021 | 0.01x | $188.22K | $-249.84K | $16.63 Million | ▼ -82.0% |
| 2020 | 0.06x | $825.05K | $-42.26K | $13.11 Million | ▲ +9.9% |
| 2019 | 0.06x | $744.32K | $608.31K | $13.00 Million | ▼ -33.6% |
| 2018 | 0.09x | $1.31 Million | $1.26 Million | $15.18 Million | ▲ +48.8% |
| 2017 | 0.06x | $977.70K | $841.22K | $16.88 Million | ▼ -63.2% |
| 2016 | 0.16x | $3.09 Million | $2.90 Million | $19.61 Million | ▼ -31.7% |
| 2015 | 0.23x | $5.67 Million | $3.35 Million | $24.58 Million | ▼ -42.8% |
| 2014 | 0.40x | $10.42 Million | $4.57 Million | $25.83 Million | ▼ -64.1% |
| 2013 | 1.12x | $27.69 Million | $8.60 Million | $24.67 Million | ▲ +91.5% |
| 2012 | 0.59x | $8.63 Million | $3.64 Million | $14.72 Million | ▼ -24.4% |
| 2011 | 0.78x | $10.78 Million | $5.24 Million | $13.91 Million | ▼ -41.5% |
| 2010 | 1.33x | $18.30 Million | $7.79 Million | $13.81 Million | ▼ -46.3% |
| 2009 | 2.47x | $26.03 Million | $10.67 Million | $10.54 Million | ▼ -8.0% |
| 2008 | 2.68x | $15.04 Million | $6.54 Million | $5.60 Million | ▲ +82.8% |
| 2007 | 1.47x | $5.79 Million | $2.80 Million | $3.94 Million | ▲ +828.5% |
| 2006 | -0.20x | $-1.54 Million | $-1.74 Million | $7.66 Million | ▼ -103.1% |
| 2005 | 6.55x | $448.32K | $-35.81K | $68.41K | ▲ +1351.9% |
| 2004 | -0.52x | $-35.81K | $-35.81K | $68.41K | ▼ -480.5% |
| 2003 | -0.09x | $-93.13K | $-93.13K | $1.03 Million | ▲ +70.1% |
| 2002 | -0.30x | $-299.20K | $-299.20K | $992.02K | ▲ +0.0% |
| 2001 | -0.30x | $-299.20K | $-299.20K | $992.02K | — |